NCT01469338: Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel |
|
|
| Terminated | 2 | 9 | US | cabazitaxel, Jevtana, RPR-116258A, taxoid XRP6258, XRP6258, prednisone, DeCortin, Deltra, octreotide pamoate, OP LAR, Sandostatin pamoate, Sandostatin pamoate LAR, SMS 201-995 pa, SMS 201-995 pa LAR, questionnaire administration, octreotide acetate, Longastatin, Longastatina, Samilstin, SMS 201-995 | University of Southern California, National Cancer Institute (NCI), Sanofi | Diarrhea, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer, Stage IV Prostate Cancer | 10/14 | 11/14 | | |
